Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ.
Benzoates
/ pharmacology
CREB-Binding Protein
/ metabolism
HEK293 Cells
Humans
Ligands
Mutation
/ genetics
Nuclear Receptor Coactivator 1
/ metabolism
PPAR gamma
/ agonists
Protein Domains
Protein Multimerization
/ drug effects
Protein Stability
/ drug effects
Reproducibility of Results
Retinoid X Receptor alpha
/ chemistry
Retinoids
/ pharmacology
Rosiglitazone
/ pharmacology
Transcriptional Activation
/ genetics
PPARγ
RXRα
allostery
cofactor recruitment
drug target
heterodimer
homodimer
homogeneous time-resolved FRET (HTRF)
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
30
06
2020
revised:
12
05
2021
accepted:
17
05
2021
pubmed:
4
6
2021
medline:
25
8
2021
entrez:
3
6
2021
Statut:
ppublish
Résumé
Nuclear receptors (NRs) activate transcription of target genes in response to binding of ligands to their ligand-binding domains (LBDs). Typically, in vitro assays use either gene expression or the recruitment of coactivators to the isolated LBD of the NR of interest to measure NR activation. However, this approach ignores that NRs function as homo- as well as heterodimers and that the LBD harbors the main dimerization interface. Cofactor recruitment is thereby interconnected with oligomerization status as well as ligand occupation of the partnering LBD through allosteric cross talk. Here we present a modular set of homogeneous time-resolved FRET-based assays through which we investigated the activation of PPARγ in response to ligands and the formation of heterodimers with its obligatory partner RXRα. We introduced mutations into the RXRα LBD that prevent coactivator binding but do not interfere with LBD dimerization or ligand binding. This enabled us to specifically detect PPARγ coactivator recruitment to PPARγ:RXRα heterodimers. We found that the RXRα agonist SR11237 destabilized the RXRα homodimer but promoted formation of the PPARγ:RXRα heterodimer, while being inactive on PPARγ itself. Of interest, incorporation of PPARγ into the heterodimer resulted in a substantial gain in affinity for coactivator CBP-1, even in the absence of ligands. Consequently, SR11237 indirectly promoted coactivator binding to PPARγ by shifting the oligomerization preference of RXRα toward PPARγ:RXRα heterodimer formation. These results emphasize that investigation of ligand-dependent NR activation should take NR dimerization into account. We envision these assays as the necessary assay tool kit for investigating NRs that partner with RXRα.
Identifiants
pubmed: 34081964
pii: S0021-9258(21)00609-8
doi: 10.1016/j.jbc.2021.100814
pmc: PMC8258697
pii:
doi:
Substances chimiques
Benzoates
0
Ligands
0
PPAR gamma
0
Retinoid X Receptor alpha
0
Retinoids
0
Rosiglitazone
05V02F2KDG
SR 11237
146670-40-8
CREB-Binding Protein
EC 2.3.1.48
Nuclear Receptor Coactivator 1
EC 2.3.1.48
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100814Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.